Market Overview

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Share:
Related GILD
Gilead Looking To Buy Incyte? It Makes Sense
Wall Street's M&A Chatter From March 10-12
Biotech ETFs Defy Trump Tweets To Rally, But What Can Send Them Higher? (Investor's Business Daily)
Related CELG
Leerink Presents: Your 2017 Biopharma Catalyst Tracker
Celgene Adds To Wednesday's Gain
Biotech ETFs Defy Trump Tweets To Rally, But What Can Send Them Higher? (Investor's Business Daily)

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.

Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.

Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.

Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

Posted-In: Biotechnology Industry Large-Cap PEG ratioTrading Ideas

 

Related Articles (ALXN + BIIB)

View Comments and Join the Discussion!